Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS

ONCSM-E.IS ✓ COMPLIANTFree checks used up today ☆ Track — members

Istanbul Stock Exchange · Healthcare · Advanced Medical Equipment & Technology ·

Turkey Micro Cap Analyst: N/A

Last Close

$2.65

▼ -9.96%

Market Cap $62.94M · Vol 607.09K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

64.14

FWD: N/A

Market Cap

$62.94M

Micro Cap

Div Yield

0.00%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

15.14

Momentum

Beta

0.97

vs Market

52W High

$8.05

66.26% below

52W Low

$2.21

13.85% above

Volume

607.09K

Avg 770.25K

P/B

15.41

Price-to-book

ROE

N/A

Return on equity

Free Float

42.29%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS (ONCSM-E.IS) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ONCSM-E.IS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-26.04%

-46.39%

-51.09%

-47.59%

YTD

-51.18%

+6.64%

-66.36%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$16.51M
Net Income	$1.17M
Revenue Growth (YoY)	+8.88%
Gross Margin	45.11%
Operating Margin	21.53%
Net Profit Margin	7.11%
ROE	N/A
ROA · ROIC	13.04% · 15.94%

P/E Ratio	64.14
Forward P/E (FY1)	N/A
PEG Ratio	0.75
P/S	8.85
P/B	15.41
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	23.85M

Technical Indicators

50-Day SMA	$4.80
200-Day SMA	$5.51
RSI (14)	15.14
Beta	0.97
52-Week High	$8.05
52-Week Low	$2.21

Volume Today	607.09K
Avg Daily Volume (30D)	770.25K
Relative Volume	0.79x
Volatility (10D)	98.06
Volatility (30D)	81.08
Free Float	42.29%

Analyst Consensus

N/A

Current Price $2.65

Mean Target N/A

52W Low$2.21 52W High$8.05

Current

Target

$2.21 $8.05

Current Analyst target

· 0 analysts

Identifiers

ExchangeIstanbul Stock Exchange

FIGIN/A

ISINTREONCO00026

CountryTurkey

Sub-IndustryMedical Diagnostic & Testing Equipment

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SRT.DE Sartorius AG +1.23% BIOT.ST Biotage AB +0.14% EUZ.DE Eckert & Ziegler SE +1.66% VREX Varex Imaging Corporation +0.38% CEVI.ST CellaVision AB +1.10%

Company Profile

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is a Turkey-based company, which is engaged in the production of medical devices. The Company manufactures electromedical and electrotherapeutic apparatus, surgical and medical instruments, and other related medical products. Oncosem Onkolojik Sistemler is specialized in the manufacturing of equipment and medical devices used in cancer treatment, and it offers fully automated chemotherapy drug preparation devices, diagnostic tests and protective equipment, and waste collection devices. The Company also manufactures hazardous waste sealing systems, chemotherapy preparation and administration consumables, Oncosem devices' components, and infusion pumps.